Lachlan Paul Deimel

Mr. Lachlan Paul Deimel

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2025 in Science
Verified
Journal Article
Open access
AMAndrew J. MacLean
Andrew J. MacLean
LDLachlan Paul Deimel
Lachlan Paul Deimel
PZPengcheng Zhou
Pengcheng Zhou
MEMohamed A. ElTanbouly
Mohamed A. ElTanbouly
JMJulia Merkenschlager
Julia Merkenschlager
MNMichel C. Nussenzweig
Michel C. Nussenzweig
Increased antibody affinity over time after vaccination, known as affinity maturation, is a prototypical feature of immune responses. Recent studies have shown that a diverse collection of B cells, producing antibodies with a wide spectrum of different affinities, is selected into the plasma cell (PC) pathway. How affinity-permissive selection enables PC affinity maturation remains unknown. We found that PC precursors (prePCs) expressing high-affinity antibodies received higher levels of T follicular helper cell (T FH cell)–derived help and divided at higher rates compared with their lower-affinity counterparts once they left the germinal center. Our findings indicate that differential cell division by selected prePCs accounts for how diverse precursors develop into a PC compartment that mediates serological affinity maturation.

22 July 2022 in Science
Verified
Journal Article
Closed access
CBCharles J. Buchanan
Charles J. Buchanan
BGBen Gaunt
Ben Gaunt
PHPeter J. Harrison
Peter J. Harrison
YYYun Yang
Yun Yang
JLJiwei Liu
Jiwei Liu
BDBenjamin G. Davis
Benjamin G. Davis
Many pathogens exploit host cell-surface glycans. However, precise analyses of glycan ligands binding with heavily modified pathogen proteins can be confounded by overlapping sugar signals and/or compounded with known experimental constraints. Universal saturation transfer analysis (uSTA) builds on existing nuclear magnetic resonance spectroscopy to provide an automated workflow for quantitating protein-ligand interactions. uSTA reveals that early-pandemic, B-origin-lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike trimer binds sialoside sugars in an “end-on” manner. uSTA-guided modeling and a high-resolution cryo–electron microscopy structure implicate the spike N-terminal domain (NTD) and confirm end-on binding. This finding rationalizes the effect of NTD mutations that abolish sugar binding in SARS-CoV-2 variants of concern. Together with genetic variance analyses in early pandemic patient cohorts, this binding implicates a sialylated polylactosamine motif found on tetraantennary N-linked glycoproteins deep in the human lung as potentially relevant to virulence and/or zoonosis.

15 January 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
LDLinnea Z. Drexhage
Linnea Z. Drexhage
SZShengpan Zhang
Shengpan Zhang
MDMaeva Dupont
Maeva Dupont
FRFranziska Ragaller
Franziska Ragaller
ESEllen Sjule
Ellen Sjule
QSQuentin Sattentau
Quentin Sattentau
Efferocytic clearance of apoptotic cells in general, and T cells in particular, is required for tissue and immune homeostasis. Transmembrane mucins are extended glycoproteins highly expressed in the cell glycocalyx that function as a barrier to phagocytosis. Whether and how mucins may be regulated during cell death to facilitate efferocytic corpse clearance is not well understood. Here we show that normal and transformed human T cells express a subset of mucins which are rapidly and selectively removed from the cell surface during apoptosis. This process is mediated by the ADAM10 sheddase, the activity of which is associated with XKR8-catalyzed flipping of phosphatidylserine to the outer leaflet of the plasma membrane. Mucin clearance enhances uptake of apoptotic T cells by macrophages, confirming mucins as an enzymatically-modulatable barrier to efferocytosis. Together these findings demonstrate a glycocalyx regulatory pathway with implications for therapeutic intervention in the clearance of normal and transformed apoptotic T cells.

23 January 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SRSreeja Roy
Sreeja Roy
HLHo-Ying Liu
Ho-Ying Liu
MJMuhammad Irwan Jaeson
Muhammad Irwan Jaeson
LDLachlan Paul Deimel
Lachlan Paul Deimel
CRCharani Ranasinghe
Charani Ranasinghe
This study demonstrates that 24 h following viral vector-based vaccination IL-13Rα2 functions as a master sensor on conventional dendritic cells (cDCs), abetted by high protein stability coupled with minimal mRNA expression, to rapidly regulate DC mediated IL-13 responses at the lung mucosae, unlike IL-13Rα1. Under low IL-13, IL-13Rα2 performs as a primary signalling receptor, whilst under high IL-13, acts to sequester IL-13 to maintain homeostasis, both in a STAT3-dependent manner. Likewise, we show that viral vector-derived IL-13 levels at the vaccination site can induce differential STAT3/STAT6 paradigms in lung cDC, that can get regulated collaboratively or independently by TGF-β1 and IFN-γ. Specifically, low IL-13 responses associated with recombinant Fowlpox virus (rFPV) is regulated by early IL-13Rα2, correlated with STAT3/TGF-β1 expression. Whilst, high IL-13 responses, associated with recombinant Modified Vaccinia Ankara (rMVA) is regulated in an IL-13Rα1/STAT6 dependent manner associated with IFN-γR expression bias. Different viral vaccine vectors have previously been shown to induce unique adaptive immune outcomes. Taken together current observations suggest that IL-13Rα2-driven STAT3/STAT6 equilibrium at the cDC level may play an important role in governing the efficacy of vector-based vaccines. These new insights have high potential to be exploited to improve recombinant viral vector-based vaccine design, according to the pathogen of interest and/or therapies against IL-13 associated disease conditions.

12 August 2025 in Cell Reports
Verified
Journal Article
Open access
LDLachlan Paul Deimel
Lachlan Paul Deimel
YNYoshiaki Nishimura
Yoshiaki Nishimura
GSGabriela S. Silva Santos
Gabriela S. Silva Santos
VBViren A. Baharani
Viren A. Baharani
BHBrianna Hernandez
Brianna Hernandez
MNMichel C. Nussenzweig
Michel C. Nussenzweig
Effective vaccines elicit B cell clonal expansion in germinal centers (GCs) that produce memory B cells and antibody-secreting plasma cells. In mice, memory B cells rarely re-enter GCs upon boosting and instead differentiate into plasma cells. However, mouse circulating memory constitutes only 1%-2% of B cells, compared to 30%-50% in primates. We examine memory and GC B cell responses in rhesus macaques immunized and boosted ipsilaterally or contralaterally with an mRNA vaccine encoding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. The neutralizing activity of antibodies cloned from the memory compartment, as well as the size of the compartment, was independent of the site of boosting. We show that memory B cells enter and undergo iterative expansion in newly developing GCs when boosting is at a site distal to the site of priming. Thus, in primates, high-affinity memory B cells constitute a reservoir that actively participates in further development of immunity irrespective of the anatomical site of vaccine boosting.

28 April 2026 in Journal of Experimental Medicine
Verified
Journal Article
Open access
DSDennis Schaefer-Babajew
Dennis Schaefer-Babajew
LBLaurine Binet
Laurine Binet
GSGabriela S. Silva Santos
Gabriela S. Silva Santos
CRChiara Ruprecht
Chiara Ruprecht
LDLachlan Paul Deimel
Lachlan Paul Deimel
MNMichel C. Nussenzweig
Michel C. Nussenzweig
Humoral immune responses are characterized by increasing antibody affinity and diversity over time. Increased affinity is mediated by a combination of immunoglobulin gene somatic mutation and iterative cycles of selection in germinal centers. Less is understood about how diversity increases. Here, we examine the role of antibody feedback in diversifying immune responses in mice that produce B cells that are incapable of secreting antibodies. To this end, we produced two strains of mice, one that expresses only membrane and secreted forms of IgM, and a second that produces only the membrane-bound form of IgM. Analysis of primary and secondary immune responses shows that antibody feedback significantly diversifies both primary and secondary immune responses even when antibodies are present at levels that are 10–30-fold lower than physiologic. The data have significant implication for sequential vaccination approaches aimed at shepherding immunity to produce broadly neutralizing antibodies to highly diversified pathogens such as HIV-1 and influenza.